Clinical Trial Update: GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GM-CSF with or without a Favrille vaccine after first-line chemotherapy and rituximab in diffuse large B-cell lymphoma has been suspend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Favrille vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: Favrille | Conditions: Lymphoma | Phase 3 | Status: SUSPENDED